NCT00607711View on ClinicalTrials.gov

Study of Oral Palifosfamide Tris in Solid Tumors

PHASE1SuspendedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Advanced Cancer
Interventions
DRUG

oral palifosfamide tris

Capsule(s) given daily for 15 days followed by a 6 day rest. This is a dose escalation arm.

Sponsors
All Listed Sponsors
lead

Alaunos Therapeutics

INDUSTRY